Who founded Cassidy Bio?

Cassidy Bio was founded by Yaniv Shmueli.

Who are Cassidy Bio's investors?

Cassidy Bio's investors include 10D, Ahren Innovation Capital, Lool Ventures.

How much funding has Cassidy Bio raised?

Cassidy Bio has disclosed $8M raised across 1 round.

Where is Cassidy Bio headquartered?

Cassidy Bio is headquartered in Tel Aviv, IL.

Cassidy Bio

Tel Aviv, IL · 7 known investors

Find your way into Cassidy Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Cassidy Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Yaniv Shmueli CTO & Co-Founder2024–2026Yaniv Shmueli is an R&D executive with over 25 years of experience in applied AI/ML systems, including work on foundational models, recommendation systems, and data infrastructure across enterprise, e-commerce, and web platforms. He is now founder of Cassidy Bio, which develops genomic foundation models to accelerate CRISPR gene therapy design.

Rom KshukCEO

Ayal Hendel CSOAyal Hendel is Chief Scientific Officer at Cassidy Bio and a former Principal Investigator in genome editing who received a 2017 ERC Grant.

Investors · 7

10Dlisted by 10DTel Aviv

How we know: 10D's portfolio page · the VCSheet dataset · Not right? Tell us

Ahren Innovation Capitallisted by Ahren Innovation CapitalCambridge, Cambridgeshire

How we know: Ahren Innovation Capital's portfolio page · funding news · calcalistech.com · Not right? Tell us

Lool VenturesreportedTel Aviv

How we know: funding news · calcalistech.com · Not right? Tell us

Also in the syndicate · 4

10D VCAION LabsAstraZenecaMerck KGaA

Funding

SEC filings, press & company announcements

$8M disclosed across 1 round · 2025

$8MSeed roundNov 2025 · 4 sources
Ahren Innovation Capital (lead), 10D VC, AION Labs, AstraZeneca, lool Ventures, Merck KGaA
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Cassidy Bio Closes $8M in Seed Fundingfinsmes.com · Nov 2025

Frequently asked questions

What does Cassidy Bio do?: Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.
Who founded Cassidy Bio?: Cassidy Bio was founded by Yaniv Shmueli.
Who are Cassidy Bio's investors?: Cassidy Bio's investors include 10D, Ahren Innovation Capital, Lool Ventures.
How much funding has Cassidy Bio raised?: Cassidy Bio has disclosed $8M raised across 1 round.
Where is Cassidy Bio headquartered?: Cassidy Bio is headquartered in Tel Aviv, IL.